My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Phasebio Pharmaceuticals Inc (PHAS)
NASDAQ:PHAS

Phasebio Pharmaceuticals Stock Investors

Based on 523,089 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold PHAS
On average, investors allocate 2.27% of their portfolios to PHAS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Neutral
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 523,089 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding PHAS

1.1%
Last 7
Days
1.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding PHAS, out of 523,089 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

PHAS Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Increased
0.02%
$2.16
Closed
0.00%
$2.28
Increased
6.59%
$2.21
Closed
0.00%
$2.36
Reduced
0.87%
$3.98
Opened
3.83%
$3.92
Opened
0.74%
$3.94
Closed
0.00%
$3.00
Closed
0.00%
$3.03
Opened
6.57%
$2.89
Based on the activity of 44,020 investors who made their portfolios public
The table shows changes in PHAS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

PHAS Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
AGTCApplied Genetic Technologies
6.07%
0.72%
20.84%
$83.16M
Healthcare
ALNAAllena Pharmaceuticals
5.68%
-1.70%
-0.90%
$54.33M
Healthcare
AQSTAquestive Therapeutics
7.67%
-2.82%
-0.11%
$216.08M
Healthcare
SRNESorrento Therapeutics
6.49%
-2.42%
-4.87%
$1.69B
Healthcare
ATNMActinium Pharmaceuticals
6.81%
-3.02%
-3.05%
$149.81M
Healthcare
AGRXAgile Therapeutics
3.09%
9.53%
10.41%
$72.84M
Healthcare
PTNPalatin Technologies
6.41%
1.84%
2.45%
$128.28M
Healthcare
CLRBCellectar Biosciences
2.62%
-1.74%
-2.92%
$40.10M
Healthcare
KALAKala Pharmaceuticals
4.55%
-3.38%
-0.23%
$102.03M
Healthcare
ADMAADMA Biologics
6.18%
-0.10%
-1.98%
$266.31M
Healthcare
Based on the activity of 523,089 active portfolios
Open your Smart Portfolio

PHAS Investor Analysis

PHAS investors under 35

Under 35

32.3%
Last 30 days
Holdings Change
7.7%
of PHAS holders
are under 35
Average Segment Performance
Monthly Return0.88%
Beta1.47
Dividend Yield7.10%
PHAS investors between 35–55

Between 35–55

1.5%
Last 30 days
Holdings Change
55.8%
of PHAS holders
are between 35–55
Average Segment Performance
Monthly Return1.09%
Beta15.98
Dividend Yield27.15%
PHAS investors over 55

Over 55

18.2%
Last 30 days
Holdings Change
36.5%
of PHAS holders
are over 55
Average Segment Performance
Monthly Return1.15%
Beta1.28
Dividend Yield7.31%
Overview of age group and performance of PHAS stock investors
See who invests in PHAS according to age group and performance.

Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
ENTBFEntheon Biomedical
MCURFMind Cure Health
INNPFInnoCan Pharma
CGEMCullinan Management
BTTXMountain Crest Acquisition II

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis